Product information

Consider XOLAIR® for your patients
Consider XOLAIR® for your patients
Allergic Asthma, Chronic Rhinosinusitis with Nasal Polyposis, Chronic Idiopathic Urticaria
Allergic Asthma, Chronic Rhinosinusitis with Nasal Polyposis, Chronic Idiopathic Urticaria

Download helpful materials

resources thumbnail

Enrollment Form

PDF
Download
resources thumbnail

UAS7 Questionnaire

PDF
Download

Consult the Product Monograph at www.novartis.com/ca-en/XolairMonograph for important information relating to contraindications, warnings, precautions, adverse reactions, drug interactions, conditions of clinical use, and dosage and administration information. The Product Monograph is also available by calling 1-800-363-8883.

Reference

  1. XOLAIR® Product Monograph. Novartis Pharmaceuticals Canada Inc., March 31, 2025.

© Novartis Pharmaceuticals Canada Inc. 2025
® XOLAIR is a registered trademark.
All rights reserved. 

June/2025
FA-11206803-1E

 
 

EN_InnovativeMeds_MemberMark 1